Atrás
Scienture Holdings Inc (SCNX) Dividendos
Gráfico del Precio de Acciones SCNX
SCNX Dividendos
Scienture Holdings Inc
$0.46
-5.07%
$-0.02
Al cierre: Mar 24, 16:00:00 GMT-4
$0.46
0%
$0
Mercado Posterior: Mar 24, 20:00:00 GMT-4
Scienture Holdings Inc Información sobre dividendosHistorial de dividendos Gráficos de dividendos
SCNX Dividendos
SCNX Crecimiento de Dividendos (YoY)
Follow-Up Questions
¿Cuál es el dividendo actual pagado por Scienture Holdings Inc y su dividendo anual?
¿Cuál es el ratio de pago de dividendos de Scienture Holdings Inc?
¿Cuál es la fecha ex-dividendo para SCNX?
¿Con qué frecuencia paga dividendos Scienture Holdings Inc?
Estadísticas clave
Cierre Anterior
$0.4847
Precio de apertura
$0.4847
Rango del día
$0.4535 - $0.4919
Rango de 52 semanas
$0.372 - $2.6
Volumen
427.4K
Volumen promedio
3.4M
Rendimiento de dividendos
12.44%
EPS (TTM)
-1.72
Cap. de mercado
$18.6M
¿Qué es SCNX?
Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. The company is headquartered in Commack, New York and currently employs 14 full-time employees. The company went IPO on 2020-02-18. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The firm's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.